Shadow AI and vendor data retention put GMP records and trade secrets at risk. AI Pulse Check panelists outline what pharma AI policies require.
|Articles|October 2, 2021
- Pharmaceutical Technology, October 2021 Issue
- Volume 45
- Issue 10
Small Bore Tubing Connectors
Colder Products Company MicroCNX Series Connectors provide an alternative to tube welding for small-volume, closed aseptic processes.
MicroCNX connectors are specifically designed for small-volume processes involving 1/16 in. (1.6 mm), 3/32 in. (2.4 mm), and 1/8 in. (3.2 mm) small-bore tubing. The connectors can be incorporated into pre-made tubing assemblies.
To use the aseptic connector, users must pinch to remove the protective cover, click together the connector halves, and pull out the protective membranes to allow flow to begin. This process is intended to be a simpler solution to traditional tube welding, which requires maneuvering the tube welder into position, equipment maintenance, and precise technique.
Articles in this issue
about 5 years ago
Automating Aseptic Manufacturingabout 5 years ago
Considering Bio/Pharma Reformulation Strategiesabout 5 years ago
Pharma Sets a Foundation for Greener API Manufacturingabout 5 years ago
Adopting Continuous Manufacturing for Solid-Dose Drug Productsabout 5 years ago
Determining Shelf Life: Reading the Stability Testing Dataabout 5 years ago
Trends Affecting Biopharmaceutical Manufacturingabout 5 years ago
European Pharmacopoeia Updates: EDQM Tackles Nitrosamine Impuritiesabout 5 years ago
Public Trust in Medicine Quality as Public Health Challenges Emergeabout 5 years ago
FDA Moves to Advance Innovative ExcipientsRelated to this article
Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.